glp 1 and diabetic retinopathy GLP-1 Drugs Ocular Disease: Between Neuroprotection and Risk PDF] GLP-1R as a Target

Albiglutide (Tanzeum) Albiglutide, marketed as Tanzeum, is a fusion protein similar to Dulaglutide

(2025) Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis

This suggests that tirzepatide is more effective in improving glucose control in patients with T2DM [87, 88]

Recent landmark studies revealed that semaglutide and tirzepatide reduce major adverse cardiac events by 20 to 25 percent, positioning GLP-1 medications as genuine preventive health tools rather than cosmetic interventions

Additionally, while the human islet donors did not have T2DM, these islet donors had BMIs consistent with an overweight condition